The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities
Frontiers in Oncology · 28.05.2026 · 16
DOI: 10.3389/fonc.2026.1784749 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 28.05.2026. Verfasst von Zhennan Ma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anorectal Surgery, Dalian University Affiliated Xinhua Hospital, Dalian, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
As a pivotal hub of cellular metabolism, NAD + metabolic reprogramming exerts a core role in colorectal cancer chemoresistance by regulating energy metabolism, DNA repair, and the immune microenvironment. The dysregulation of synthetic and catabolic pathways mediated by key molecules such as NAMPT, SIRT1, and PARP constitutes a crucial mechanism underlying chemoresistance development. Targeted intervention strategies against NAD + metabolism, including precursor supplementation, inhibitor administration, and combination therapy, have exhibited remarkable anti-cancer potential and represent promising translational strategies for reversing chemoresistance. However, clinical translation of these strategies is severely impeded by tumor metabolic heterogeneity, the lack of dynamic NAD + monitoring technologies and insufficient tissue specificity of targeted drugs. By leveraging emerging techniques including multi-omics integration, organoid models, nano-delivery systems, and dynamic imaging, in-depth dissection of metabolic heterogeneity and development of personalized intervention regimens can provide novel and effective avenues to overcome the predicament of colorectal cancer chemoresistance, which holds important translational research value and clinical application significance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anorectal Surgery, Dalian University Affiliated Xinhua Hospital, Dalian, China.
- Obstetrical Ward 1, Dalian Women and Children Medical Center, Dalian, China.
Zitieren
APA
Ma, Z., Gong, X., & Liu, F. (2026). The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1784749
Vancouver
Ma Z, Gong X, Liu F. The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1784749
BibTeX
@article{Ma2026,
author = {Ma, Zhennan and Gong, Xiuqing and Liu, Fuquan},
title = {The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1784749}
}
EUVIMED